Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
PaperCitations, authors & open-access status
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,952 citations, 2010 year and bronze oa status.
2,952
Citations
2010
Year
bronze
OA Status